Internal Medicine, Rheumatology · Secaucus, NJ
NPI
1760682173
Since 2007
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
714 10th St
Secaucus, NJ, 07094
Phone (551) 257-7038
Groups this clinician bills Medicare through
Medicare paid, 2024
$181K
13,412 services
Medicare patients, 2024
171
Average age 70
Drug cost, 2024
$4.8M
2,732 prescriptions
Company payments, 2025
$179
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sushama Mody was code J1010 (injection, methylprednisolone acetate, 1 mg), 910 times for 17 patients. In total Sushama Mody billed 13,412 services in 39 codes, and Medicare paid $181K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-12-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 910 | 17 | $0.10 | $92.14 |
| 99214 Office E&M - Established | Office | 282 | 126 | $95.11 | $27K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 117 | 79 | $13.36 | $1,564 |
| 20611 Joint Injection | Office | 68 | 26 | $111.64 | $7,592 |
| 96372 Injection Administration | Office | 39 | 16 | $11.64 | $454 |
| 99213 Office E&M - Established | Office | 33 | 19 | $76.79 | $2,534 |
| J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 32 | 16 | $5.34 | $171 |
| 99204 Office E&M - New | Office | 32 | 32 | $132.87 | $4,252 |
| 99215 Office E&M - Established | Office | 26 | 19 | $156.78 | $4,076 |
| 20610 Joint Injection | Office | 21 | 14 | $58.52 | $1,229 |
By year: 2022 $288K for 20,172 services; 2023 $217K for 13,569 services; 2024 $181K for 13,412 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sushama Mody prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 273 prescriptions and refills. In total Sushama Mody wrote 2,732 Medicare prescriptions that cost $4.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 273 | 717 | 103 | $6,370 |
| Diclofenac Sodium Generic | 237 | 272 | 95 | $22K |
| Gabapentin Generic | 206 | 354 | 62 | $2,650 |
| Prednisone Generic | 174 | 263 | 81 | $647 |
| Tramadol Hcl Generic | 173 | 186 | 32 | $1,500 |
| Celecoxib Generic | 137 | 256 | 67 | $6,947 |
| Humira(Cf) Pen Adalimumab | 136 | 157 | 22 | $1.1M |
| Hydroxychloroquine Sulfate Generic | 113 | 292 | 44 | $4,866 |
| Cyclobenzaprine Hcl Generic | 109 | 145 | 54 | $697 |
| Enbrel Sureclick Etanercept | 95 | 113 | 17 | $851K |
| Pregabalin Generic | 78 | 126 | 22 | $1,956 |
| Meloxicam Generic | 70 | 171 | 42 | $340 |
| Xeljanz Xr Tofacitinib Citrate | 65 | 84 | 11 | $480K |
| Folic Acid Generic | 64 | 180 | 25 | $558 |
| Rinvoq Upadacitinib | 63 | 91 | 11 | $571K |
Brand drugs: - claims; generic drugs: 2,109 claims; opioid claims: 186.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sushama Mody $179 ($179 in general payments such as food, travel and fees) from 2 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $164.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.